Electroencephalogram (EEG) and Electroconvulsive Therapy(ECT) Response in Schizophrenia
NCT ID: NCT04220099
Last Updated: 2020-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2020-01-07
2020-07-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Longitudinal Effect of Electroconvulsive Therapy on Schizophrenia and Bipolar Disorder: a MRI Study
NCT03651674
EEG and Behavioral Correlates of Temporal Prediction in the Tactile Modality in Schizophrenia
NCT05296720
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
NCT05542212
Schizophrenia Sensory Gating Deficit With Quetiapine
NCT00536783
50 Hz vs. 25 Hz Magnetic Seizure Therapy for Schizophrenia
NCT03003156
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
schizophrenia patients needed ECT treatment
Whether patients need ECT treatment are assessed by clinicians according to American Psychiatric Association(APA) guidelines.
Electroconvulsive therapy(ECT)
Patients recieve 8-sessions ECT treatments and those kinds of drugs they take since they were recruited remain unchanged during this study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Electroconvulsive therapy(ECT)
Patients recieve 8-sessions ECT treatments and those kinds of drugs they take since they were recruited remain unchanged during this study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients needed ECT treatment assessed by clinicians using American psychological Association(APA) guidelines.
* symptoms must be of at least moderate severity (PANSS score \>71)
* age between 18 to 60 years old
* medications will be stable for at least four weeks prior to ECT, and there will be no dose changes unless medically necessary
Exclusion Criteria
* pregnancy or prepare to have a baby
* current use of any Antiepileptic drugs
* history of taking any kinds of Physicotherapeutics within 6 months
* severe psychotic symptoms that make patients could not accomplish the clinical interview
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Mental Health Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhen Wang
vice-president
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhen Wang, Ph.D M.D
Role: PRINCIPAL_INVESTIGATOR
Shanghai Mental Health Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SMHC-SZD-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.